Is there a new drug beyond floxuridine for intra-arterial hepatic chemotherapy in liver metastases from colorectal cancer?

被引:13
作者
Fiorentini, G [1 ]
Rossi, S [1 ]
Bernardeschi, P [1 ]
Cantore, M [1 ]
Guadagni, S [1 ]
机构
[1] City Gen Hosp, Dept Oncol, Florence, Italy
关键词
D O I
10.1200/JCO.2005.99.297
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2105 / 2105
页数:1
相关论文
共 9 条
[1]   The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: Shoot the messenger [J].
Berg, RW ;
Ferguson, PJ ;
DeMoor, JM ;
Vincent, MD ;
Koropatnick, J .
CURRENT DRUG TARGETS, 2002, 3 (04) :297-309
[2]  
Davies MM, 1999, CLIN CANCER RES, V5, P325
[3]   Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: Results of a phase I clinical study [J].
Fiorentini, G ;
Lucchi, SR ;
Giovanis, P ;
Cantore, M ;
Guadagni, S ;
Papiani, G .
TUMORI JOURNAL, 2001, 87 (06) :388-390
[4]   Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: A phase II clinical study [J].
Fiorentini, G ;
Rossi, S ;
Denticol, P ;
Bernardeschi, P ;
Calcinai, A ;
Bonechi, F ;
Cantore, M ;
Guadagni, S ;
De Simone, M .
TUMORI JOURNAL, 2003, 89 (04) :382-384
[5]   Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma [J].
Gorlick, R ;
Metzger, R ;
Danenberg, KD ;
Salonga, D ;
Miles, JS ;
Longo, GSA ;
Fu, J ;
Banerjee, D ;
Klimstra, D ;
Jhanwar, S ;
Danenberg, PV ;
Kemeny, N ;
Bertino, JR .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1465-1469
[6]   CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues [J].
Guichard, S ;
Terret, C ;
Hennebelle, I ;
Lochon, I ;
Chevreau, P ;
Frétigny, E ;
Selves, J ;
Chatelut, E ;
Bugat, R ;
Canal, P .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :364-370
[7]  
GUPTA E, 1994, CANCER RES, V54, P3723
[8]   Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer [J].
Kemeny, N ;
Jarnagin, W ;
Gonen, M ;
Stockman, J ;
Blumgart, L ;
Sperber, D ;
Hummer, A ;
Fong, Y .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3303-3309
[9]  
Rivory LP, 1995, CANCER CHEMOTH PHARM, V36, P176